Armodafinil 72189-0261-30
- Manufacturer
- Direct Rx
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIV
- Marketing Start
- September 13, 2021
- Listing Expires
- December 31, 2026
- Application
- NDA021875
Active Ingredients
| Ingredient | Strength |
|---|---|
| Armodafinil | 250 mg/1 |
Selected Package
72189-0261-30Selected30 TABLET in 1 BOTTLE (72189-261-30)